期刊文献+

马来酸桂哌齐特注射液联合阿司匹林肠溶片治疗急性脑梗死的临床观察 被引量:5

下载PDF
导出
摘要 急性脑梗死是神经内科的常见病和多发病,目前对脑梗死的治疗多采用改善脑缺血、防止血栓形成、保护神经细胞等综合治疗方法。马来酸桂哌齐特注射液(商品名克林澳,每支80mg/2mL,由北京四环制药有限公司生产)是一种新型心脑血管治疗药物,具有腺苷增效及弱钙通道阻滞的双重作用,同时还有扩张血管、增加红细胞柔韧性、降低血液黏度、改善血循环及营养脑细胞的多重作用,对血压及脉搏影响不大。
出处 《中国神经免疫学和神经病学杂志》 CAS 2009年第5期386-387,共2页 Chinese Journal of Neuroimmunology and Neurology
  • 相关文献

参考文献4

二级参考文献10

共引文献60

同被引文献39

  • 1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 2Karpov RS, Koshelskaja OA, Vrublevskij AV, et al. Clini- cal efficacy and safety of mildronate in patients with ischemic heart disease and chronic heart failure [ in Russian ] . Kardi- ologija, 2000, 6: 69-74.
  • 3Dziak LA, Golik VA. Use of mildronate for the treatment of patients with circulatory encephalopathy against a background of stenosis of major arteries of the head. Lik Sprava, 2003 , (5-6) : 98-101.
  • 4Liepinsh E, Skapare E, Svalbe B, et al. Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats. Eur J Pharmacol, 2011 , 658 ( 2-3 ) : 277 -283.
  • 5Suslina ZA, Fedorova TN, Maksimova M, et al. Antioxidant activity of mildronate and L-canlitine in the treatment of pa-tients with cerebrovascular diseases. Eksp Klin Farmakol, 2003, 66(3): 32-35.
  • 6Svalbe B, Zvejniece L, Vavers E, et al. Mildronate treat- ment improves functional recovery following middle cerebral ar- tery occlusion in rats. Behav Brain Res, 2011, 222(1) : 26-32.
  • 7Dziak LA, Golik VA. Use of mildronate for the treatment of patients with circulatory eneephalopathy against a background of stenosis of major arteries of the head. Lik Sprava, 2003 , (5-6) : 98-101.
  • 8Ol ' binskaia LI, Golokolenova GM. Use of mindronate in car- diac insufficiency in patients with ischemic heart disease. Klin Med (Mosk) , 1990, 68(1): 39-42.
  • 9Sisetskii AP, Artiukh VP, Sakharchuk II, et al. The charac- teristics of the action of mildronate ( dihydrate 3 - ( 2, 2, 2 - trimethylhydrazine ) propionate ) on the red blood parameters in heart failure. Eksp Klin Farmakol, 1992, 55 ( 3 ) : 20 - 21.
  • 10Beketov AI, Mametova AN, Polevik IV, et al. Comparative characteristics of cerebrovascular protective effects of mildr- onate, riboxine, and their combination during modeling of cerebral hemodynamics disturbance. Eksp Klin Farmakol, 2000, 63(6) : 18-21.

引证文献5

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部